Christopher W Sands
Overview
Explore the profile of Christopher W Sands including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chappell K, Shah S, Cutshall B, Sands C
Nurse Pract
. 2020 Apr;
45(5):11-12.
PMID: 32332227
No abstract available.
2.
3.
Richardson A, Tolley E, Hartmann J, Reedus J, Bowlin B, Finch C, et al.
Respir Med
. 2016 Dec;
123:150.
PMID: 27916482
No abstract available.
4.
Jain N, Savani M, Agarwal M, Sands C
Ther Adv Drug Saf
. 2016 Dec;
7(6):236-238.
PMID: 27904741
No abstract available.
5.
Self T, Shah S, March K, Sands C
J Asthma
. 2016 Nov;
54(7):714-722.
PMID: 27858495
Objective: A review of the evidence was conducted regarding asthma associated with the use of cocaine, heroin, and marijuana. Data Sources: A search of the English literature was performed via...
6.
Richardson A, Tolley E, Hartmann J, Reedus J, Bowlin B, Finch C, et al.
Respir Med
. 2016 Oct;
119:135-140.
PMID: 27692135
Introduction: Approximately 1 in 5 hospitalized COPD patients are readmitted within 30 days of discharge. CHF coexists in more than 20% of patients with COPD, and is associated with early...
7.
Self T, Owens R, Sakaan S, Wallace J, Sands C, Howard-Thompson A
Curr Med Res Opin
. 2015 Dec;
32(4):613-20.
PMID: 26695107
Introduction: The purpose of this review article is to summarize the literature on diseases that are documented to have an effect on response to warfarin and other VKAs. Methods: We...
8.
Self T, Wallace J, Sakaan S, Sands C
South Med J
. 2015 Oct;
108(10):637-43.
PMID: 26437201
Objectives: Numerous factors are well documented to affect the response to vitamin K antagonists (VKA), including dietary vitamin K, other drugs, age, pharmacogenetics, and disease states. Body weight is perhaps...
9.
Self T, Oliphant C, Reaves A, Richardson A, Sands C
Thromb Res
. 2014 Dec;
135(1):5-8.
PMID: 25456000
Numerous factors affect the response to vitamin K antagonists (VKA) including age, dietary vitamin K, other drugs, pharmacogenetics, and disease states. In antithrombotic guidelines, fever is mentioned as a factor...
10.
Wallace J, Reaves A, Tolley E, Oliphant C, Hutchison L, Alabdan N, et al.
J Thromb Thrombolysis
. 2012 Sep;
36(1):96-101.
PMID: 23015280
Achieving therapeutic anticoagulation with warfarin is complicated by substantial inter-patient and intra-patient variability with numerous factors known to influence dose requirements. Obesity is one factor for which there remains no...